Patents by Inventor Roumei XING

Roumei XING has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANTI-CLAUDIN18 ANTIBODIES
    Publication number: 20240270839
    Abstract: Provided are anti-CLDN18 (in particular, anti-CLDN18.2) antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical composition comprising the same and the uses thereof.
    Type: Application
    Filed: September 26, 2021
    Publication date: August 15, 2024
    Inventors: Yangsheng QIU, Hongtao LU, Roumei XING, Jingfeng YU, Rui GAO
  • NOVEL ANTI-CD39 ANTIBODIES
    Publication number: 20210388105
    Abstract: Provided are anti-CD39 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof.
    Type: Application
    Filed: August 26, 2020
    Publication date: December 16, 2021
    Inventors: Yangsheng QIU, Meiling SUN, Roumei XING, Dan XU, Yufei SHI, Jinfeng ZHAO, Qinglin DU, Zhihao WU, Rui GAO, Robert H. ARCH, Hongtao LU
  • NOVEL ANTI-SIRPA ANTIBODIES
    Publication number: 20210347908
    Abstract: Provided are anti-SIRP? antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same and the uses thereof.
    Type: Application
    Filed: August 18, 2020
    Publication date: November 11, 2021
    Inventors: Xiaofeng NIU, Jingfeng YU, Jinfeng ZHAO, Fengli WANG, Dan XU, Roumei XING, Zhihao WU, Qinglin DU, Yangsheng QIU, Robert H. ARCH, Hongtao LU